Once again, UCLA's phase I results are trotted out as having something to do with NWBO. What about status of their own (stalled) phase II trial? Surely they have recruited some patients and there has been some follow-up time. It's an open label trial, how's it going?
The prostate cancer results are from a phase II trial that is almost 10 years old now. Even if they did get to work right away the patent on it would expire before there was anything to market. And, what are they going to use for the vaccine antigen? After settling the Lonza lawsuit they are back to square one.
This company is all about hype and taking credit for other's work. They need to get busy doing something real or move aside. Now the problem is restructuring the company's balance sheet. Why would that be necessary? They haven't accomplished anything since the last time they did a reverse split. Another reverse split on the way?